Share This

Hot News @ 放棄固態按鍵設計瑞聲

 < Previous page   
Related Keyword:疫苗 , 專利 , 瑞聲
Related Concept:美國放棄新冠疫苗專利 , 疫苗股急挫康希諾 , 瑞聲首季純利 , 收入毛利率
 
股匯市況.不斷更新|悶局未止港股輕微高開83點復星彈半成(附互動圖片) | 蘋果日報 @ 2021-05-07T12:
A股靠穩,上證綜指升5點或0.15%,報3446點;深證成指升33點或0.23%,報14243點;創業板指升7點或0.23%,報3021點。 美股企穩,外圍未有大動向,恆指 ...
Keyword:疫苗 專利
Concept:美國放棄新冠疫苗專利 , 疫苗股急挫康希諾
美國放棄新冠疫苗專利累港美疫苗股急挫康希諾、復星醫藥曾挫逾兩成、BioNTech盤前跌7% - 香港經濟日報- 即時新聞頻道- 即市財經- 股市 @ 2021-05-07T12:
美國拜登政府周三公布,美國將放棄新冠疫苗的知識產權專利,拖累本港上市的疫苗股今日急跌。負責引入輝瑞BioNTech疫苗到大中華區銷售的復星 ...
Keyword:疫苗 專利
Concept:美國放棄新冠疫苗專利 , 疫苗股急挫康希諾
瑞聲(02018.HK):隨著產品升級相信毛利率將見40% @ 2020-05-16T20:
瑞聲科技(02018.HK)董事總經理莫祖權表示,首季業績受到肺炎疫情影響,整個2月未有錄得收入,而員工等固定成本則維持。相信次季疫情穩定,加上全球智能手機 ...
Keyword:瑞聲
Concept:瑞聲首季純利 , 收入毛利率
 < Previous page   

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.